Mechanistic bases of vessel diameter regulation by Plexind1 - Resubmission
- Institution
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY
- Principal investigator
- Jesús Torres-Vázquez
- Funding
- $750K
- Duration
- 2022–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Blood vessels must be properly shaped and placed and have a hierarchical organization with characteristic and distinct calibers to perform their vital circulatory function. In particular, vascular caliber is the primary determinant of blood flow properties. Thus, abnormalities in luminal morphometry disrupt blood circulation and decrease cardiovascular health. We found that Semaphorin-Plexind1 (Sema-Plxnd1) signaling, known for its role in guiding the anatomical patterning of the vasculature, plays a novel blood flow-dependent role in determining the caliber of the axial midline vessels (the major artery and vein of the body). Our aims are as follows. (1) To define the signaling pathways and cellular mechanisms by which Plxnd1, its Sema3 ligands, and blood flow regulate the caliber of these vessels. (2) To define the structural bases of Plxnd1-dependent vessel caliber sizing and the role of Semas and flow forces as modulators of Plxnd1 expression, apicobasal targeting, and flow mechanosensing activity. We will use zebrafish as our primary model system to exploit its unique experimental advantages for studying vascular development, function, and signaling in vivo. We will also perform experiments with mice to determine if the receptor's novel role is conserved in mammals. Finally, to further illuminate how Sema ligands and circulatory forces modulate Plexin-D1 expression, localization, and function, we will perform studies with human endothelial cell systems under tunable flow conditions.
LOADING MOONBASE SCORE
Questions for NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · New York University School of Medicine68
EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTION
Daniel Pearce Depledge · $529K · 2020–2026
- NIH · New York University School of Medicine67
RELAXaHEAD: A Behavioral Approach to Remote Migraine Management in Primary Care
Mia Minen · $2.3M · 2022–2028
- NIH · New York University School of Medicine65
Multinuclear MRI to Assess Joint Homeostasis after Knee Injury
Guillaume Madelin · $661K · 2022–2027